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Endothelial cells (ECs) are critical mediators of blood pressure (BP)
regulation, primarily via the generation and release of vasorelaxants,
including nitric oxide (NO). NO is produced in ECs by endothelial NO
synthase (eNOS), which is activated by both calcium (Ca2+)-dependent
and independent pathways. Here, we report that intracellular Ca2+
release from the endoplasmic reticulum (ER) via inositol 1,4,5-trisphos-
phate receptor (IP3R) is required for Ca2+-dependent eNOS activation.
EC-specific type 1 1,4,5-trisphosphate receptor knockout (IP3R1−/−)
mice are hypertensive and display blunted vasodilation in response
to acetylcholine (ACh). Moreover, eNOS activity is reduced in both
isolated IP3R1-deficient murine ECs and human ECs following IP3R1
knockdown. IP3R1 is upstream of calcineurin, a Ca2+/calmodulin-
activated serine/threonine protein phosphatase. We show here
that the calcineurin/nuclear factor of activated T cells (NFAT) path-
way is less active and eNOS levels are decreased in IP3R1-deficient
ECs. Furthermore, the calcineurin inhibitor cyclosporin A, whose
use has been associated with the development of hypertension,
reduces eNOS activity and vasodilation following ACh stimulation.
Our results demonstrate that IP3R1 plays a crucial role in the EC-
mediated vasorelaxation and the maintenance of normal BP.
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Hypertension (HTN) is a major cause of morbidity and mortalityaffecting millions of adults worldwide (1, 2). Globally, among
the ∼17 million deaths caused by cardiovascular diseases, nearly half
can be attributed to complications of HTN (3–9). In addition, va-
sodilator drugs that activate nitric oxide (NO) production have been
used to treat HTN for decades (4, 10). Calcineurin (also known
as protein phosphatase 2B), is a Ca2+/calmodulin-activated serine/
threonine protein phosphatase. Calcineurin inhibitors are first-line
immunosuppressants used in organ transplantation (11, 12). How-
ever, calcineurin inhibition causes HTN in up to 70% of patients
(13), and the exact underlying mechanisms are not fully understood.
Vascular endothelial cells (ECs), located at the interface be-
tween the vessel wall and blood, release vasorelaxants that in-
fluence vascular smooth muscle tone in response to mechanical
(e.g., shear stress) and biochemical stimuli (14, 15). These stimuli
induce a rapid increase in intracellular Ca2+ ([Ca2+]i) in ECs
activating Ca2+-dependent signaling pathways, resulting in re-
lease of endothelium-derived relaxing factors, including NO (14,
16–19). Mice lacking endothelial nitric oxide synthase (eNOS)
develop severe HTN (20). However, how eNOS is regulated
in vivo remains essentially unclear. The modulation of both
plasma membrane Ca2+ entry and endoplasmic reticulum (ER)
Ca2+ release is critical in EC function (21, 22).
Moreover, recent meta-analysis and genome-wide associa-
tion studies in hypertensive individuals have linked type 1 1,4,5-
trisphosphate receptor (IP3R1), a major [Ca2+]i release channel
(23, 24), to high blood pressure (BP) (25, 26). On these grounds,
we sought to investigate in detail the functional role of the IP3R1/
Ca2+/calcineurin/nuclear factor of activated T cells (NFAT)/eNOS
pathway in BP regulation.
Results and Discussion
Generation and Characterization of Endothelium-Specific IP3R1 Knockout
Mice. Previous studies have reported embryonic lethality in calci-
neurin B mutant and NFATc3 and NFATc4 double-knockout mice
models (27). Furthermore, there are three isoforms of calcineurin A
and one of calcineurin B in ECs (28) plus four isoforms of NFAT
(29). Thus, genetic approaches to elucidate the functions of these
molecules are problematic. Therefore, to dissect the IP3R1/Ca2+/
calcineurin/NFAT/eNOS pathway, and to understand better the
molecular mechanisms underlying BP regulation, we examined the
role of IP3R1 in the Ca2+-dependent eNOS activation in ECs. We
generated EC-specific IP3R1 knockout (EC IP3R1−/−) mice result-
ing from crosses of floxed IP3R1 mice with Tie2Cre mice (Fig. S1 A
and B). IP3R1 expression was significantly reduced in vascular ECs
isolated from EC IP3R1−/−mice compared with mice harboring the
IP3R1flox/flox allele (IP3R1fl/fl) (Fig. S1C). In contrast, levels of
mRNA encoding the two other isoforms of IP3R, IP3R2 and IP3R3,
did not exhibit compensatory up-regulation in vascular ECs from
EC IP3R1−/−mice (Fig. S1C). Immunofluorescence analysis did not
detect IP3R1 protein in vascular ECs from EC IP3R1−/− mice (Fig.
S1D). Additionally, EC IP3R1−/− mice exhibited normal embryonic
development (Fig. S2).
Effect of Endothelial Disruption on BP. Strikingly, mean arterial
pressure (measured using radiotelemetry) was significantly ele-
vated in freely ambulating EC IP3R1−/− mice by 3 mo of age (Fig.
1A). These findings were confirmed by measuring BP using a
Millar catheter (Fig. S3A) or tail-cuff (Fig. S3B). At 6 mo of age,
chronic HTN resulted in cardiac enlargement and overall reduced
function in EC IP3R1−/− mice (Table S1). Mesenteric arteries
exhibited markedly thickened tunica media (Fig. S4 A and B) with
an increased media/lumen ratio (Fig. S4C) in EC IP3R1−/− mice.
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In addition, both cardiac fibrosis and renal fibrosis were augmented
in 6-mo-old EC IP3R1−/− mice (Fig. S4 D and E). Taken together,
these data show that EC IP3R1−/−mice have a chronic hypertensive
phenotype with typical target-organ damage, including the heart,
kidney, and vasculature. Further studies are needed to investigate in
detail the potential involvement of the regulation of sodium ex-
cretion in the kidney and other renal pathways (30, 31).
Defective Vasodilation in EC IP3R1−/−Mice.EC IP3R1−/−mice exhibited
a blunted vasodilatory response to i.v. ACh (Fig. 1B). However, in-
jection of the endothelium-independent vasodilator sodium nitro-
prusside (SNP; an NO donor) caused an equivalent BP reduction in
both IP3R1fl/fl and EC IP3R1−/− mice (Fig. 1B), indicating that the
vasodilatory response to NO was intact.
Responses to the vasoconstrictor phenylephrine (an α1-adreno-
receptor agonist) were intact in aortas and mesenteric arteries
from both IP3R1fl/fl and EC IP3R1−/− mice (Fig. 1 C and E).
However, the ACh-induced aortic relaxation was markedly blunted
(by ∼41%) in EC IP3R1−/− mice compared with IP3R1fl/fl mice
(Fig. 1D). Responses to the Ca2+ ionophore A23187 were also
markedly impaired (by ∼23%) in EC IP3R1−/− mice (Fig. S5).
Similarly, there was a significant reduction in the response to
ACh (Fig. 1F) in EC IP3R1−/− mesenteric arteries. Importantly,
responses to SNP were comparable between IP3R1fl/fl and
EC IP3R1−/− mice in both vascular districts (Fig. S6 A and B).
Diminished ACh-Induced Ca2+-Dependent NO Production in EC IP3R1−/−
Mice. To confirm that the observed blunted vasodilation was
due to deficient IP3R1-mediated ER Ca2+ release, we exam-
ined the ACh-induced Ca2+ response in isolated aortic ECs.
Addition of ACh elicited a rapid dose-dependent increase in
[Ca2+]i in IP3R1
fl/fl ECs that was significantly reduced in IP3R1−/−
ECs. Incubation of ECs with Xestospongin C (Xec; an IP3R in-
hibitor) also inhibited the rise in [Ca2+]i in response to ACh in
both groups (Fig. 2B). Similar results were obtained using a sec-
ond IP3R inhibitor (2-aminoethoxydiphenyl borate; Fig. S7).
These genetic and pharmacological data indicate that IP3R1 ac-
tivation contributes to the ACh-induced [Ca2+]i increase in vas-
cular ECs. The increase in ACh-induced EC NO was blunted in
EC IP3R1−/− mice (Fig. 2C), and NO production in control mice
was reduced by Xec or L-NG-nitroarginine methyl ester (L-NAME)
(Fig. 2D), indicating that IP3R1-mediated ER Ca2+ plays a pivotal
role in EC NO generation.
EC NO is produced primarily by eNOS following agonist stim-
ulation, and eNOS activity is dependent on Ca2+-calmodulin (17,
32). Under basal conditions, eNOS activity in ECs isolated from EC
IP3R1−/− mice was reduced compared with eNOS activity in ECs
from IP3R1fl/fl mice (Fig. 2E). ACh (10 μM) increased eNOS ac-
tivity by 2.6-fold in IP3R1fl/fl mice, whereas such an increase was not
observed in EC IP3R1−/− mice (Fig. 2E).
Defective eNOS Activity Due to Decreased Expression and Phosphorylation.
eNOS activity is determined both by basal protein level and by
enzymatic activity, which is regulated by phosphorylation (33).
HTN was associated with reduced eNOS protein in EC IP3R1−/−
mesenteric arteries (Fig. 3A), as well as attenuated eNOS phos-
phorylation at Ser1176 in response to ACh stimulation (Fig. 3A).
Moreover, phosphorylation of eNOS at Thr494, which is an in-
hibitory site (34), was increased in EC IP3R1−/− mesenteric ar-
teries (Fig. 3B). IP3R1-deficient human ECs, generated by
transfecting IP3R1 siRNAs into human umbilical vein endothelial
Fig. 1. Effect of endothelial disruption of IP3R1 in ECs on BP and vascular reactivity. (A) Mean arterial pressure (MAP) recorded by radiotelemetry in at least
seven IP3R1fl/fl and EC IP3R1−/− mice. (B) MAP measured by an intra-arterial Millar catheter in IP3Rfl/fl and EC IP3R1−/− mice in response to ACh and SNP in-
jection. *P < 0.05 vs. IP3Rfl/fl mice; #P < 0.05 vs. baseline (n ≥ 6 mice per each group) by Student’s t test. (C) Vasoconstrictor reactivity to the α1-adrenoreceptor
agonist phenylephrine (PE) in aorta arteries in IP3R1fl/fl and EC IP3R1−/− mice. (D) Endothelium-dependent relaxation to ACh in aorta arteries. There was a
significant decrease in potency (rightward shift) of the concentration response curve to ACh in the aortic arteries of EC IP3R1−/−mice. ***P < 0.001 vs. IP3R1fl/fl
mice by Student’s t test. (E) Vasoconstrictor reactivity to PE in mesenteric arteries. (F) Endothelium-dependent relaxation to ACh in mesenteric arteries. There
was a significant decrease in potency (rightward shift) of the concentration response curve to ACh in the mesenteric arteries of EC IP3R1−/− mice. Data are
presented as mean ± SEM (n = 12–20 rings from six mice per group for aorta arteries, n = 8 for isolated mesenteric arteries). **P < 0.01 vs. IP3R1fl/fl mice by
Student’s t test.
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cells (HUVECs), exhibited an ∼50% decrease in eNOS protein
(Fig. 3C) and mRNA (Fig. 3D).
Effects of IP3R1 Deletion on the Calcineurin/NFAT Pathway in ECs.
The calcineurin/NFAT pathway has been identified as being
located downstream of the angiotensin II type 2 receptor to
promote eNOS expression in the myocardium, where it is be-
lieved to protect against cardiac hypertrophy (35). We examined
NFAT translocation to the nucleus to determine whether NFAT
might be a regulator of eNOS expression in ECs. Indeed, nuclear
translocation of NFAT was reduced in response to ACh stimu-
lation in both IP3R1 knockdown HUVECs (Fig. 3 E and F) and
isolated IP3R1-deficient ECs (Fig. S8). Taken together, these
data provide a mechanism for the reduced eNOS levels observed
in IP3R1-deficient ECs whereby decreased ER Ca2+ release
impairs activation of downstream calcineurin/NFAT signaling.
The calcineurin inhibitor cyclosporin A (CsA) significantly
reduced ACh-induced vasodilation, but did not reduce SNP-
mediated vasodilation in IP3R1fl/fl mice (Fig. S9). Preincubation
of HUVECs with CsA for 1 h blocked ACh-induced NFAT
translocation (Fig. 3 E and F). eNOS activation by ACh was also
inhibited by CsA in a dose-dependent manner (Fig. 3G). These
data suggest that the IP3R1/calcineurin/NFAT signaling pathway
plays a key role in ACh-induced eNOS activity in vascular ECs.
Stimulation of muscarinic M1 receptors in ECs by ACh acti-
vates phospholipase C-γ1, resulting in IP3 production and IP3R-
mediated Ca2+ release from the ER (36). Our data show that
increased [Ca2+]i, in turn, activates the calcineurin/NFAT path-
way, resulting in increased eNOS expression and activity in
vascular ECs (Fig. 4). Although Ca2+-induced eNOS activation
appears to be an important pathway for vasodilation, we cannot
rule out the involvement of other vasodilators [e.g., prostaglandin
Fig. 2. ACh-induced Ca2+ increase and NO production in isolated aortic ECs. (A) Representative images (Upper) and traces (Lower) of endothelial Ca2+ re-
sponses to ACh measured with the fluorescence Ca2+ indicator Fluo-4. (Scale bars: 20 μm.) (B) Summarized data regarding endothelial Ca2+ increase. Data are
presented as mean ± SEM (n = 30–40 cells from six mice per each group). *P < 0.05; **P < 0.01. NS, not significant. (C) Representative traces of endothelial NO
increase in response to ACh. (D) Summarized data of maximal endothelial NO fluorescence. Data are presented as mean ± SEM (n = 20–30 cells from six mice
per group). **P < 0.01. (E) NOS activity measured in isolated aortic ECs with (+) or without (−) 10 μM ACh treatment at 37 °C for 10 min. Data are shown as
mean ± SEM of at least three independent experiments. ***P < 0.001 vs. IP3R1fl/fl ECs within the same group; #P < 0.001 vs. untreated IP3R1fl/fl ECs; NS, not
significant vs. untreated EC IP3R1−/− ECs (all by Student’s t test).







I2, endothelium-derived hyperpolarizing factor (EDHF)],
particularly in mesenteric arteries, where EDHF is a major
vasodilator downstream of increased [Ca2+]i (18). In addition,
eNOS posttranslational modification at other sites upon ACh
stimulation may contribute to the low activity in EC IP3R1−/−
mice (Fig. 3 A and B). Phosphorylation of eNOS at Ser1176 is
a positive regulator of eNOS activity and is mediated by Ca2+/
calmodulin/calmodulin-dependent protein kinase II (CaMKII) cascade,
Fig. 3. Calcineurin in eNOS regulation. (A) Expression of eNOS and phosphorylation of eNOS at Ser1176 (p-S1176) in lysates from mesenteric arteries pre-
pared under basal conditions or after 30-min ACh incubation in IP3R1fl/fl and EC IP3R1−/− mice. The graph shows the densitometric evaluation (n = 3). *P <
0.05; **P < 0.01. (B) Phosphorylation of eNOS at Thr494 (p-T494) in lysates from mesenteric arteries in IP3R1fl/fl and EC IP3R1−/− mice. Data are presented as
mean ± SEM of three independent experiments. **P < 0.01. (C) Immunoblots conducted in HUVECs transfected with scrambled or IP3R1-specific siRNAs. Cells
were harvested 24 h, 48 h, and 72 h after transfection. (D) Relative IP3R1 and eNOS mRNA levels were measured by real-time RT-quantitative PCR in HUVECs
after indicated times of transfection. β-Actin was used as an internal control. (A–D) *P < 0.05; **P < 0.01; ***P < 0.001 vs. scrambled by Student’s t test.
(E) Representative immunofluorescence images of NFAT intracellular localization in transfected HUVECs, with or without CsA (1 μM, 1 h) and ACh (10 μM,
10 min) treatment. NFAT, red; DAPI, blue. (Magnification: 20×.) (Scale bars: 20 μm.) (F) Quantification of cells with nuclear-translocated NFAT. More than 30
cells were calculated for each condition, and data are presented as mean ± SEM of three independent experiments. ***P < 0.001 vs. siScrambled treated with
ACh only, analyzed by Student’s t test. (G) Isolated aortic ECs were pretreated with gradient concentrations (0, 10, 100, and 1,000 nM) of CsA at 37 °C for 1 h,
followed by ACh stimulation and NOS activity measurement as described in Fig. 2E. *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant vs. 0 nM CsA-
treated cells of respective group, analyzed by Student’s t test.
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whereas the phosphorylation of Thr494 inhibits eNOS catalytic
activity (33). Calcineurin has been reported to dephosphorylate
eNOS at Ser116 in human and bovine ECs (37); however, this site
shows very low homology in murine EC eNOS. Further investi-
gations are warranted to explore in detail the role of IP3R1 in
the modulation of EC bioenergetics (38), which might contribute
to the observed hypertensive phenotype.
Taken together, our results demonstrate that EC IP3R1
channels are crucial for the activation of the calcineurin/NFAT/
eNOS signaling pathway, which, in turn, plays a fundamental role
in the maintenance of normal BP.
Materials and Methods
Animal Studies. Exon 4 of the gene encoding for IP3R1 was targeted by
flanking it with loxP sites (Fig. S1A). Methodologies for the generation of
embryonic stem cell-derived embryos have been described elsewhere (39).
IP3R1fl/fl mice were bred with Tie2-Cre transgenic mice to obtain an EC-specific
ablation of IP3R1 (EC IP3R1 KO). Genotypes were verified by PCR (Fig. S1B and
Table S2). All mice were backcrossed into the C57BL/6 background for >10
generations. BP was recorded via radiotelemetry, Millar catheter, and tail-cuff,
as previously described (39). Vascular reactivity of mouse thoracic aortic and
mesenteric arterial ring preparations was determined following established
protocols (40).
A detailed description of materials and methods can be found in SI Ma-
terials and Methods.
Ethical Approval.All studies were performed according to protocols approved
by the Institutional Animal Care and Use Committee of Columbia University
and according to NIH guidelines. All experiments were conducted by oper-
ators who were blinded to the genotypes of the animals. No samples, mice,
or data points were excluded from the reported analyses.
Statistics. All results are presented as mean ± SEM. Statistical analysis was
performed using an unpaired two-tailed Student’s t test unless otherwise
indicated. P values <0.05 were considered significant.
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SI Materials and Methods
Targeted Deletion of IP3R1 in ECs. Exon 4 of the gene encoding for
IP3R1was targeted by flanking it with loxP sites (Fig. S1A). Detailed
methodologies for the generation of embryonic stem cell-derived
embryos have been described elsewhere (39). Mice harboring the
IP3R1fl/fl allele were bred with Tie2-Cre transgenic mice to obtain
an EC-specific ablation of IP3R1 (EC IP3R1 KO). Genotypes were
verified by PCR (Fig. S1B). All mice were backcrossed into the
C57BL/6 background for >10 generations. All animal studies were
performed according to protocols approved by the Institutional
Animal Care and Use Committee of Columbia University and
according to NIH guidelines. All in vivo and in vitro experiments
were conducted on male mice by operators who were blinded to the
genotypes of the animals. No samples, mice, or data points were
excluded from the reported analyses.
Radiotelemetric BP Recording. BP was recorded in conscious, freely
moving mice using radiotelemetric transmitters (TA11PA-C10;
Data Sciences International) implanted into the aortic arch (39).
After 10 d of recovery, BP was recorded for 24 h in mice left
undisturbed and maintained on a 12-h light/12-h dark cycle. Data
were acquired for 2 min every 15 min, and the average values for
MAP were calculated for every time point.
BP Measurement by Millar Catheter.BP was measured as previously
described (17). Briefly, mice were anesthetized by isoflurane
inhalation and maintained by mask ventilation. Direct BP and
heart rate measurements were performed with the use of a 1.0-
French Mikro-Tip catheter (SPR1000; Millar Instruments),
which was advanced through the right external carotid artery
and placed in the descending aorta. After implantation, the
catheter was connected to a transducer (Gould Instruments
Systems) to record BP and heart rate for 15 min.
BP Measurement by Tail-Cuff. BP was measured using a tail-cuff
method that relies on volume/pressure recording technology
(Coda 6; Kent Scientific Corporation). BP wasmeasured each day
at the same time.
Vascular Reactivity ex Vivo.The vascular reactivity of mouse thoracic
aortic and mesenteric arterial ring preparations was determined as
previously described and validated (40, 41). Briefly, 3- to 6-mo-old
mice were killed, and the mesentery artery and thoracic aorta were
rapidly removed and dissected in ice-cold Krebs solution (119 mM
NaCl, 4.7 mMKCl, 2.5 mM CaCl2, 1 mMMgCl2, 25 mMNaHCO3,
1.2 mM KH2PO4, and 11 mM D-glucose). Mesenteric artery rings
and thoracic aorta segments were mounted in a Multi Myograph
System (510; Danish Myo Technology A/S), and modifications in
arterial tone were recorded. Cumulative concentration response
curves to phenylephrine (PE) were assessed in order to evaluate the
contractility response. To evaluate vasorelaxation and the integrity
of the endothelium layer, cumulative concentration response curves
to ACh (1 nM to 30 μM), A23187 (1 nM to 10 μM), and SNP
(1 nM to 10 μM) were tested on PE (1 μM) precontracted rings.
EC Isolation. After euthanization, murine aortas were quickly
harvested, removed from adipose and connective tissues, cut
through the longitudinal axis, and suspended in 1 mL of dissoci-
ation solution [55 mM NaCl, 80 mM Na-glutamate, 6 mM KCl,
2 mM MgCl2, 0.1 mM CaCl2, 10 mM glucose, and 10 mM Hepes
(pH 7.3)] containing 0.5 mg/mL neutral protease and 1 mg/mL
elastase (Worthington). After digestion for 1 h at 37 °C, type 1
collagenase (Worthington) was added to the dissociation solution
to a final concentration of 0.5 mg/mL, and digestion was contin-
ued for an additional 2 min at 37 °C. Aortas were then transferred
to 1 mL of Ca2+-free dissociation solution, and cells were released
by pipetting gently for about 10 times. Isolated ECs were collected
by centrifugation at 100 × g for 1 min.
Ca2+ Imaging. Confocal Ca2+ imaging of ECs was performed as
previously described (42, 43). Briefly, isolated aortic ECs were
incubated with 10 μM Fura-2:00 AM (Invitrogen) in normal
Tyrode’s solution, containing 135 mM NaCl, 4 mM KCl, 1.8 mM
CaCl2, 1 mM MgCl2, 10 mM Hepes, 1.2 mM NaH2PO4•2H2O,
and 10 mM glucose (pH 7.36) adjusted with NaOH for 15 min at
room temperature. After loading, the cells were washed several
times and transferred to a recording chamber. Confocal im-
aging was performed by excitation with a 488-nm light from the
argon laser of a Zeiss 5 live inverted confocal microscope (63×
oil immersion lens). Data were analyzed using Image J soft-
ware (NIH).
Measurement of NO by DAF-FM Dye. Isolated aortic ECs were
loaded with 20 μM NO-sensitive fluorescent dye: DAF-FM
(4-amino-5-methylamino-2, 7-difluorofluorescein diacetate; In-
vitrogen) for 30 min at room temperature. Cells were then re-
suspended in Tyrode’s solution (1.8 mM Ca2+). DAF fluorescence
confocal images were acquired in the x–y mode (Zeiss 5 live
inverted confocal microscope, 63× oil immersion lens), with
488-nm excitation with an argon ion laser and a 510- to 530-nm
emission filter. The fluorescence values were corrected for the
background fluorescence from a region of the image without
cells (F − F0), and the fluorescence/background ratio [(F − F0)/F0]
was calculated. All images were processed and analyzed using Fiji
software.
Histology. Embryos or tissues were fixed in 10% formaldehyde
overnight and processed for paraffin embedding. Hematoxylin
and eosin (H&E) staining was performed on 7-μm sections fol-
lowing standard protocols (41). Fibrosis was evaluated by Mas-
son’s trichrome staining (Sigma) according to the manufacturer’s
protocol. Mesenteric artery morphometric analysis was per-
formed with ImageJ software by measuring the circumference of
the external elastic lamina and internal elastic lamina. Media
thickness and the media/lumen ratio were calculated to evaluate
vessel remodeling as described (40).
Immunoblotting.Mouse mesenteric arteries were harvested, quickly
rinsed in PBS, immediately frozen in liquid nitrogen, and stored
at −80 °C. Frozen tissues or HUVECs were homogenized in
150 mM NaCl, 25 mM Tris·HCl (pH 7.5), 5 mM EDTA, 1%
Nonidet P-40, 0.4% deoxycholic acid, 1 mM Na3VO4, and
complete protease inhibitors. Protein concentrations were
determined using the bicinchoninic acid assay (BCA) assay. Ten to
20 μg of protein was size-fractionated on SDS/PAGE and
immunoblotted. Immunoblotting was performed as previously
described and validated (43–46) using the following antibodies:
eNOS (catalog no. 610297; BD Biosciences), phosphor-eNOS
(Thr-495, catalog no. 9574s; Cell Signaling Technology), phospho-
eNOS (Ser-1177, catalog no. 9571s; Cell Signaling Technology),
and GAPDH (catalog no. 2118; Cell Signaling Technology).
Immunofluorescence. Paraffin-embedded tissues were deparaffi-
nized, hydrated, and antigen-retrieved before immunostaining
with IP3R1 antibody (1:100). Isolated aortic ECs were seeded on
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35-mm glass-bottomed dishes (MatTek Corporation) precoated
with poly-L-lysine solution (Sigma) and stained with NFATc3
antibody (1:50; Santa Cruz Biotechnology). Cy3-labeled sec-
ondary antibody (1:1,000; Abcam) was incubated for 1 h at room
temperature, followed by mounting with SlowFade Gold anti-
fade reagent with DAPI (Thermo Fisher Scientific). Pictures
were captured with a Zeiss 5 live inverted confocal microscope
(63× oil immersion lens) (40).
RT-Quantitative PCR. Total RNAs were extracted using TRIzol
(Invitrogen) and subjected to synthesize cDNA (RR047A;
Takara). SYBR Premix Ex Taq II (RR820A; Takara) was used to
quantify corresponding gene expression according to the manu-
facturer’s instructions. Detailed primer sequences are listed in
Table S1. All reactions were run in triplicate and incubated in
96-well plates at 95 °C for 2 min, followed by 40 cycles of 95 °C
for 5 s and 60 °C for 30 s using the ABI 7500 Fast Real-Time
PCR Detection System (39). RT-quantitative PCR data were
analyzed using the comparative threshold method and normal-
ized to the expression of β-actin.
eNOS Activity Measurement. Isolated aortic ECs were stimulated
with or without ACh (10 μM; 37 °C for 5 min) or CsA (10 nM,
100 nM, 1 μM; 37 °C for 1 h), followed by NOS activity assay
detection (ENOS-100; BioAssay Systems). Briefly, 25 μL of cell
lysates was mixed with 100 μL of NOS working reagent at 37 °C
for 20 min to produce NO. NO production was then measured
following reduction of nitrate to nitrite using the Griess method
(data obtained at OD540). Concentrations of cell lysates were






ð20 * Slope *ConcentrationÞðU=gÞ.
Cell Culture.Pooled HUVECs were purchased from the American
Type Culture Collection (ATCC) and cultured in vascular cell
basal medium with the Endothelial Cell Growth Kit-BBE (ATCC).
For knockdown experiments, scrambled or IP3R1 siRNAs were
incubated with Lipofectamine 2000 Transfection Reagent
(Thermo Fisher Scientific) and transfected into cells according
to the manufacturer’s instruction. Experiments were conducted
after 72 h of transfection (47). Cells of passages 3–5 were used
for all experiments.
Statistics.All results are presented as the mean ± SEM. Statistical
analysis was performed using an unpaired two-tailed Student’s
t test unless otherwise indicated. P values less than 0.05 were
considered significant.
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Fig. S1. Generation and characterization of EC IP3R1−/− mice. (A) Schematic diagram of the procedure for generating the EC IP3R1−/− mice. (Top) Wild-type
(WT) IP3R1 gene locus. Red boxes indicate exons 3–5. In the targeting vector, a loxP site was inserted at both sides of exon 4, followed by a phosphogylcerol
kinase-gene neocassette and a diphtheria toxin A marker (DTA) inserted at the 3′ end of exon 4. A floxed allele was generated after deleting the neocassette.
(Bottom) IP3R1 KO allele obtained by crossing floxed mice with Tie2Cre mice. (B) Representative genotyping PCR results from C57 WT (Right), IP3R1fl/fl (Middle),
and EC IP3R1−/− (Left) mice. The 416-bp product indicates a floxed allele with loxP insertion. Tie2Cre was also confirmed by PCR in KO mice. (C) IP3R subtype
mRNA levels were evaluated by real-time RT-quantitative PCR from vascular ECs, using β-actin as an internal control. Values are shown as mean ± SEM of four
independent experiments, each in triplicate. **P < 0.01 compared with IP3R1fl/fl, Student’s t test. ns, not significant. (D) Representative immunofluorescence
images of aortas from IP3R1fl/fl and EC IP3R1−/− mice stained for IP3R1 (red). Nuclei were counterstained with DAPI (blue). Yellow arrowheads indicate ECs
beyond the inner elastic lamina, and blue arrowheads indicate smooth muscle cells surrounding ECs. (Magnification: 63×.) (Scale bars: 10 μm.)
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Fig. S2. Normal embryonic development of EC IP3R−/−mice. Pregnant IP3R1fl/fl and EC IP3R1−/−mice were killed, and embryos of embryonic day (E) 5.5, E 6.5, E
8.5, E 13.5, E 15.5, and E 17.5 were fixed and paraffin-embedded. H&E staining was conducted on sagittal sections of embryos. No abnormalities were found in
EC IP3R1−/− embryonic development compared with IP3R1fl/fl embryos. [Scale bars: E 5.5 and E 6.5: 100 μm (zoom: 25 μm); E 8.5: 200 μm (zoom: 25 μm); E 13.5:
4 mm (zoom: 100 μm); and E 15.5 and 17.5: 4 mm (zoom: 200 μm).]
Fig. S3. BP measured by intra-arterial catheter and tail-cuff. (A) Mean arterial pressure (MAP) recorded by invasive catheter. (B) Systolic BP (SBP) was measured
by tail-cuff and calculated in at least seven mice from IP3R1fl/fl and EC IP3R1−/− mice. All data are presented as mean ± SEM. *P < 0.05 vs. IP3R1 fl/fl mice by
Student’s t test.
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Fig. S4. Targeted end-organ damage in EC IP3R1−/− mice. (A) Representative pictures of H&E staining on paraffin-embedded mesenteric arteries of 6-mo-old
IP3R1fl/fl and EC IP3R1−/−mice. Data statistics of media thickness (B) and media/lumen ratio (C) calculated from at least eight vessels of four individual mice per
each group are shown. *P < 0.05; ***P < 0.001 vs. IP3R1fl/fl mice analyzed by Student’s t test. Masson’s trichrome staining on paraffin-embedded sections shows
massive fibrosis (indicated by blue stain) of both the heart (D) and kidney (E) in 6-mo-old EC IP3R1−/− mice, which is hardly detected in IP3R1fl/fl littermates.
(Scale bars: 50 μm.)
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Fig. S5. Vascular reactivity in response to endothelium-dependent agonist A23187. Endothelium-dependent relaxation to A23187 in aortic segments. Data
are presented as mean ± SEM (n = 4–8 rings from at least three mice per group). *P < 0.05.
Fig. S6. Vascular reactivity in response to endothelium-independent agonist. (A) Endothelium-independent relaxation to SNP in aorta arteries. (B) Endothelium-
independent relaxation to SNP in mesenteric arteries. Data are presented as mean ± SEM (n = 12–20 rings from six mice per group for aorta arteries, n = 8 for
isolated mesenteric arteries).
Fig. S7. Effect of 2-aminoethoxydiphenyl borate (2-APB) on ACh-induced [Ca2+]i release. Summarized data of ACh-induced endothelial Ca
2+ increase. Data are
presented as mean ± SEM (n = 30–40 cells from six mice per each group). *P < 0.05.
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Fig. S8. NFAT translocation upon ACh stimulation in aortic ECs. (A) Representative immunofluorescence images of NFAT intracellular localization in time-
dependent, ACh-treated aortic ECs. Yellow arrowheads indicate ECs with NFAT nuclear translocation. NFAT, red; DAPI, blue. (Magnification: 20×.) (Scale bars:
20 μm.) (B) Data statistics of percentages of cells with nuclear-translocated NFAT (translocated cell number/total cell number * 100%). More than 50 cells were
calculated for each condition, and data are presented as mean ± SEM of three independent experiments. *P < 0.05; NS, not significant vs. IP3R1fl/fl ECs within
the same group, analyzed by Student’s t test.
Fig. S9. Effect of CsA treatment on vascular reactivity. (A) Endothelium-dependent relaxation in response to ACh in aortic segments. (B) Endothelium-
independent relaxation in response to SNP in aortic segments. Data are presented as mean ± SEM (n = 8–12 rings from three mice per group for aortic arteries).
**P < 0.01.
Table S1. Characteristics of 3- and 6-mo-old IP3R1fl/fl and EC
IP3R1−/− mice
Parameters
3 mo 6 mo
IP3R1fl/fl EC IP3R1−/− IP3R1fl/fl EC IP3R1−/−
BW, g 24.1 ± 0.9 24.4 ± 1.2 25.6 ± 0.9 25.5 ± 1.3
HR, bpm 508 ± 48 506 ± 62 502 ± 52 510 ± 56
HW/BW, mg/g 4.02 ± 0.7 4.8 ± 0.8 4.03 ± 0.5 6.01 ± 0.8*
HW/TL, mg/mm 5.6 ± 0.8 5.9 ± 0.9 5.6 ± 0.9 7.7 ± 1.1*
EF, % 78.3 ± 3.2 77.8 ± 3.8 78.5 ± 3.6 61.2 ± 3.3*
IVS, mm 0.73 ± 0.05 0.75 ± 0.06 0.72 ± 0.04 0.89 ± 0.07*
LVPW, mm 0.72 ± 0.04 0.73 ± 0.03 0.71 ± 0.05 0.90 ± 0.05*
bpm, beats per minute; BW, body weight; EF, ejection fraction; HR, heart
rate; HW, heart weight; IVS, interventricular septum; LVPW, left ventricular
posterior wall; TL, tibial length. n = 8–10 mice per group.
*P < 0.05 vs. IP3R1fl/fl.
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Table S2. Primer sequences for real-time RT-quantitative PCR
Gene Primer sequence PCR product, bp
mIP3R1 F: ACCTTAGGCTTGGTTGATGAC 102
R: AGGACATAGCTTAAAGAGGCAG
mIP3R2 F: AGACTCTCAGCTCGCTCTGG 99
R: GGCCACGACATCCTGTAACT
mIP3R3 F: ACATCCTGGCTGAAGACACC 93
R: AAAGGTCTCCACCTCCGTCT
mβ-Actin F: GATCAAGATCATTGCTCCTCCTG 183
R: AGGGTGTAAAACGCAGCTCA
hIP3R1 F: GTTAGAACTGAAGAACAATGCCTC 163
R: TCCATCCTCAAATTCCACTTCAC
heNOS F: CCTGTGTATGGATGAGTATGAC 186
R: CGGATCTTATAACTCTTGTGCTG
hβ-Actin F: AAGATCAAGATCATTGCTCCTCC 193
R: TTGTCAAGAAAGGGTGTAACGC
F, forward; h, human; m, mouse; R, reverse.
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